INSPRA 50 MG
Country: Israel
Language: English
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
EPLERENONE 50 MG
Available from:
PFIZER PHARMACEUTICALS ISRAEL LTD
ATC code:
C03DA04
Pharmaceutical form:
FILM COATED TABLETS
Administration route:
PER OS
Manufactured by:
PFIZER PGM, FRANCE
Therapeutic group:
EPLERENONE
Therapeutic indications:
Inspra is indicated, in addition to standard therapy including beta-blockers, to reduce the risk of cardiovascular mortality and morbidity in stable patients with left ventricular dysfunction (LVEF < 40 % ) and clinical evidence of heart failure after recent myocardial infarction.
Authorization date:
2011-06-01
